- Life Sciences
- White Paper
Pharma Quality: Time to Transition from Fixing to Prevention
Is it right time for Pharma Quality to transit from fixing to prevention
- Overview
TCS is here to make a difference through technology.
Leading the way in innovation for over 50 years, we build greater futures for businesses across multiple industries and 131 countries.
-
Industries
-
Services
-
Products and Platforms
-
Research & Innovation
- Overview
We’re in it for good, driving positive change for the benefit of all.
Our expert, committed team put our shared beliefs into action – every day. Together, we combine innovation and collective knowledge to create the extraordinary.
-
About Us
-
Leadership
-
In the news
- Overview
Extraordinary expertise leads to remarkable results.
We share news, insights, analysis and research – tailored to your unique interests – to help you deepen your knowledge and impact.
-
Perspectives
-
Topics
- Overview
Want to be a global change-maker? Join our team.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
-
India
-
Americas
-
Asia Pacific
-
Europe and UK
-
Middle East and Africa
Top Results
Showing
10
01 - 07
The paper focuses on predicting and preventing failures in quality testing using technologies not available in the past. It highlights the problems in biopharma upstream, tablet manufacturing, and other related industries.
Related reading
Automating Systematic Literature Reviews for Cost-effective Results
White Paper
|
01 Dec 2022
How the World Entered the Business of Human Microbiome
White Paper
|
13 Nov 2022
Modernizing Pharma Regulatory Knowledge Management
White Paper
|
27 Oct 2022
Blockchain in pharma: Promoting a sustainable ecosystem
White Paper
|
24 Oct 2022
Transformation starts here
Integrated ecosystems are key to better patient outcomes.
Talk to our expertsFind out more
©2022 TATA Consultancy Services Limited